A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany

Background and objectives: Demand for assisted reproduction technology (ART) in Germany is high, with 100,844 treatment cycles during 2016. Many ART procedures involve ovarian stimulation with follicle stimulating hormone (FSH). Recently, biosimilar FSH products have become available. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Weiguang, Lloyd, Adam, Falla, Edel, Roeder, Claudia, Papsch, Rudiger, Bühler, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524790/
https://www.ncbi.nlm.nih.gov/pubmed/31191040
http://dx.doi.org/10.2147/IJWH.S193048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524790/
https://www.ncbi.nlm.nih.gov/pubmed/31191040
http://dx.doi.org/10.2147/IJWH.S193048

Ejemplares similares